ENDRA Life Sciences Inc. — Director's Dealing 2021

Apr 30, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2021-02-11

Reporting Person: Thornton Michael Milos (Chief Technology Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-11	Common Stock	A	22815	$0.00	Acquired	316525	Direct

Footnotes

F1: Represents restricted stock units paid as a 2020 annual bonus by the Issuer to the Reporting Person, which fully vested upon grant.